SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populations

SARS-CoV-2 variants have continuously emerged even as highly effective vaccines have been widely deployed. Reduced neutralization observed against variants of concern (VOC) raises the question as to whether other antiviral antibody activities are similarly compromised, or if they might compensate fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hederman, Andrew P., Natarajan, Harini, Wiener, Joshua A., Wright, Peter F., Bloch, Evan M., Tobian, Aaron A.R., Redd, Andrew D., Blankson, Joel N., Rottenstreich, Amihai, Zarbiv, Gila, Wolf, Dana, Goetghebuer, Tessa, Marchant, Arnaud, Ackerman, Margaret E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516864/
https://www.ncbi.nlm.nih.gov/pubmed/36172122
http://dx.doi.org/10.1101/2022.09.15.22280000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516864/
https://www.ncbi.nlm.nih.gov/pubmed/36172122
http://dx.doi.org/10.1101/2022.09.15.22280000

Ejemplares similares